AI for patient selection in cancer immunotherapy.
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Funding round Ellogon, an Amsterdam cancer-immunotherapy AI startup, raised EUR1M from ROM InWest and UvA Ventures Holding. | $1.1M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.